Canada markets closed

Khiron Life Sciences Corp. (KHRN.V)

TSXV - TSXV Real Time Price. Currency in CAD
Add to watchlist
0.0800+0.0050 (+6.67%)
At close: 03:53PM EST
Currency in CAD

Valuation Measures4

Market Cap (intraday) 18.39M
Enterprise Value 14.92M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)0.94
Price/Book (mrq)0.62
Enterprise Value/Revenue 0.92
Enterprise Value/EBITDA -0.52

Trading Information

Stock Price History

Beta (5Y Monthly) N/A
52-Week Change 3-59.09%
S&P500 52-Week Change 3-11.22%
52 Week High 30.2800
52 Week Low 30.0650
50-Day Moving Average 30.0955
200-Day Moving Average 30.1446

Share Statistics

Avg Vol (3 month) 3101.77k
Avg Vol (10 day) 3125.56k
Shares Outstanding 5216.39M
Implied Shares Outstanding 6N/A
Float 8203.28M
% Held by Insiders 15.01%
% Held by Institutions 11.11%
Shares Short (Nov 14, 2022) 4146.86k
Short Ratio (Nov 14, 2022) 42.2
Short % of Float (Nov 14, 2022) 4N/A
Short % of Shares Outstanding (Nov 14, 2022) 40.07%
Shares Short (prior month Oct 13, 2022) 4219.68k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3May 23, 2018
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2021
Most Recent Quarter (mrq)Sept 29, 2022


Profit Margin -189.99%
Operating Margin (ttm)-107.82%

Management Effectiveness

Return on Assets (ttm)-20.74%
Return on Equity (ttm)-74.68%

Income Statement

Revenue (ttm)16.14M
Revenue Per Share (ttm)0.09
Quarterly Revenue Growth (yoy)-3.80%
Gross Profit (ttm)6.37M
EBITDA -15.71M
Net Income Avi to Common (ttm)-30.66M
Diluted EPS (ttm)-0.1920
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)1.94M
Total Cash Per Share (mrq)0.01
Total Debt (mrq)2.56M
Total Debt/Equity (mrq)9.46
Current Ratio (mrq)2.02
Book Value Per Share (mrq)0.13

Cash Flow Statement

Operating Cash Flow (ttm)-15.01M
Levered Free Cash Flow (ttm)-9.76M